Previous close | 0.0667 |
Open | 0.0540 |
Bid | 0.0000 x 0 |
Ask | 0.0000 x 0 |
Day's range | 0.0540 - 0.0600 |
52-week range | 0.0110 - 0.0950 |
Volume | |
Avg. volume | 43,260 |
Market cap | 11.718M |
Beta (5Y monthly) | 1.11 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
LONDON, Ontario, March 12, 2024--Indiva Limited (the "Company" or "Indiva") (TSXV:NDVA), the leading Canadian producer of cannabis edibles, is pleased to announce a second private placement offering pursuant to the listed issuer financing exemption of a minimum of 10,940,000 units of the Company (each, a "Unit") and a maximum of 40,940,000 Units, at a price of $0.10 per Unit, for minimum gross proceeds to the Company of $1,094,000 and maximum gross proceeds of $4,094,000 (the "Offering").
LONDON, Ontario, March 04, 2024--Indiva Limited (the "Company" or "Indiva") (TSXV:NDVA), the leading Canadian producer of cannabis edibles, is pleased to announce the closing of the first tranche (the "First Tranche") of its previously announced private placement offering pursuant to the listed issuer financing exemption pursuant to Part 5A of National Instrument 45-106 – Prospectus Exemptions ("NI 56-106"), first announced on January 22, 2024, and then amended and restated on February 28, 2024
LONDON, Ontario, February 28, 2024--Indiva Limited (the "Company" or "Indiva") (TSXV:NDVA), the leading Canadian producer of cannabis edibles, is pleased to announce that, it has filed an amended and restated offering document dated February 28, 2024 (the "Amended and Restated Offering Document") in connection with its previously announced non-brokered private placement (the "LIFE Offering") pursuant to the listed issuer financing exemption under Part 5A of National Instrument 45-106 – Prospectu